Inventor · disambiguated record
Richard Kroczek
Also filed as: KROCZEK RICHARD
11 granted patents·5 pending applications·337 citations·filing 1998–2020
92Inventor score
Files withKROCZEK RICHARD4BUNDERSREPUBLIK DEUTSCHLAND3BUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRAESIDE3BUNDERSREPUBLIK DEUTSCHALND1BUNDERSREPUBLIK DEUTSCHLAND LE1
Top patents by PatentIndex Score
16 records- 0194US7722872B2Treatment of cancer with antibodies to costimulating polypeptide of T cellsBUNDERSREPUBLIK DEUTSCHLAND LE·Filed 2007·Granted May 25, 2010·68 cites·8 claims
- 0292US7132099B2Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptideBUNDERSREPUBLIK DEUTSCHLAND·Filed 2001·Granted Nov 7, 2006·52 cites·10 claims
- 0391US7306800B2Treatment of autoimmune disorders with antibodies to costimulating polypeptide of T cellsBUNDERSREPUBLIK DEUTSCHLAND·Filed 2003·Granted Dec 11, 2007·42 cites·5 claims
- 0491US7125551B2Methods for treatment of asthmatic disorders using a monoclonal antibody to 8F4 polypeptideBUNDERSREPUBLIK DEUTSCHALND·Filed 2001·Granted Oct 24, 2006·50 cites·5 claims
- 0590US8318905B2Antibodies for depletion of ICOS-positive cells in vivoKROCZEK RICHARD·Filed 2005·Granted Nov 27, 2012·23 cites·14 claims
- 0689US8916155B2Method for the treatment of T cell mediated conditions by depletion of ICOS-positive cells in vivoBUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRÄSIDEN·Filed 2012·Granted Dec 23, 2014·20 cites·16 claims
- 0786US7259247B1Anti-human T-cell costimulating polypeptide monoclonal antibodiesBUNDERSRESPUBLIK DEUTSCHALAND·Filed 1998·Granted Aug 21, 2007·81 cites·75 claims
- 0872US10849963B2Medicament for use in a method of inducing or extending a cellular cytotoxic immune responseBUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRAESIDE·Filed 2015·Granted Dec 1, 2020·1 cites·26 claims
- 0968US12090194B2Medicament for use in a method of inducing or extending a cellular cytotoxic immune responseBUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRAESIDE·Filed 2020·Granted Sep 17, 2024·0 cites·12 claims
- 1056US10688165B2Medicament for use in a method of inducing or extending a cellular cytotoxic immune responseBUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRAESIDE·Filed 2015·Granted Jun 23, 2020·0 cites·17 claims
- 1154US10703817B2System for delivery into XCR1 positive cell and uses thereofKROCZEK RICHARD·Filed 2008·Granted Jul 7, 2020·0 cites·6 claims
- 1254US2008118513A1Treatment of immune disorders with antibodies to costimulating polypeptide of T cellsBUNDERSREPUBLIK DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 1354US2022073630A1A peptide-mhc-i-antibody fusion protein for therapeutic use in a patient with amplified immune responseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1450US2012045447A1T cell costimulating polypeptides and uses thereofKROCZEK RICHARD·Filed 2010·Application pending·0 cites
- 1549US2004001831A1Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disordersMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1642US2013245236A1Antibodies to the chemokine receptor xcr1KROCZEK RICHARD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Kroczek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →